Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

ImmunityBio (IBRX) Shares Repurchased (2016 - 2019)

ImmunityBio (IBRX) has disclosed Shares Repurchased for 4 consecutive years, with $2.0 million as the latest value for Q4 2019.

  • Quarterly Shares Repurchased rose 777.19% to $2.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2020, down 10.23% year-over-year, with the annual reading at $2.5 million for FY2019, 996.93% up from the prior year.
  • Shares Repurchased for Q4 2019 was $2.0 million at ImmunityBio, up from $228000.0 in the prior quarter.
  • The five-year high for Shares Repurchased was $11.4 million in Q2 2017, with the low at $228000.0 in Q4 2018.
  • Average Shares Repurchased over 4 years is $3.7 million, with a median of $2.6 million recorded in 2016.
  • The sharpest move saw Shares Repurchased plummeted 91.77% in 2018, then soared 777.19% in 2019.
  • Over 4 years, Shares Repurchased stood at $3.9 million in 2016, then decreased by 29.83% to $2.8 million in 2017, then tumbled by 91.77% to $228000.0 in 2018, then soared by 777.19% to $2.0 million in 2019.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $2.0 million, $228000.0, and $2.8 million for Q4 2019, Q4 2018, and Q4 2017 respectively.